On January 16, total COVID-19 tally of India reached to 1,05,42,841. The country reported 15,158 new COVID-19 cases in last 24 hours and active cases stands at 2,11,033. With new 16,977 discharges, total number reached to 1,01,79715. 175 deaths were reported in last 24 hours, taking cumulative toll to 1,52,093. According to ICMR, total number of samples tested up to 11th January is 18,57,65,491 and of these, 8,03,090 samples were tested yesterday.
On January 15, India reported 15,677 new COVID-19 cases and 189 deaths in last 24 hours. The active cases stands at 2,10,l06. With new 15,848 discharges, total number reached to 1,01,62,082. 189 deaths were reported in last 24 hours, taking cumulative toll to 1,51,954. According to ICMR, total number of samples tested up to 14th January is 18,49,62,401 and of these, 7,30,096 samples were tested yesterday.
Dr Samiran Panda, scientist, India Council of Medical Research (ICMR) said that Bharat Biotech’s Covaxin will also provide immunity against covid-19 mutants. Panda added that India has taken a smart vaccination approach. “Covaxin presents to the immune system a wide array of antigens,” said Panda. He added, “The array of proteins and range of cells are the soldiers of immunity which will be developed following vaccination. So that will be able to address the mutants as well. I’m not tremendously worried and we don’t have any scientific evidence as yet that the mutants are going to challenge the efficacy of the vaccine.” Panda added, “Within 10-12 months, the vaccine has come out and this underlines the superiority, ability and the commitment of the scientists of India and I would say this is phenomenal.” Watch the full video for more.
Credit: HT Digital Content Duration: 04:36Published